New MTPConnect Podcast: Inventia’s Skin Printing Robot Set To Revolutionise Wound Repair

Banner Image

19 October 2022

Two decades after the tragic Bali bombings, we are reminded in recent news stories of many of the survivors who had to deal with devastating burns injuries and undergo skin grafts and multiple surgeries to stay alive.

World renowned burns surgeon Professor Fiona Wood treated many of these burns patients and helped to develop a new technology to treat burns – a ‘spray on skin’ which is now in use in over 30 countries.

Professor Wood lends her expertise

As a surgeon and a scientist, Professor Wood is now lending her expertise to a new project being led by Inventia Skin, a Sydney-based start-up on a mission to revolutionise wound repair.

Inventia Skin is developing Ligō, a skin printing robot that delivers rapid and precise regenerative cellular therapy products directly onto a wound and could help to treat difficult to heal skin burns.

So, it’s timely that MTPConnect’s latest podcast features a chat with Inventia Life Science’s Chief Executive Officer, Dr Julio Ribeiro, and Chief Technology Officer, Dr Aidan O'Mahony, as they prepare to unveil the robot to the world at the international medical technology trade fair, Medica 2022, in November.

Printing a patient’s own skin cells directly onto the wound site

Several partners – high profile scientists and physicians – including leading bioprinting researcher, Professor Gordon Wallace have joined Professor Wood to provide their expertise to the project, which will endeavour to print a patient’s own cells using the skin printing robot, embedded in an optimised matrix material, directly onto the wound site to accelerate and improve healing after skin injury.

This Inventia Skin project was awarded $1 million through MTPConnect’s BioMedTech Horizons program, an initiative of the Medical Research Future Fund, to support development of the bioprinting system.

Find out more as MTPConnect hosts Caroline Duell, Director Media and Communications, and Elizabeth Stares, Director BioMedTech Horizons program, dig deeper with the Inventia team to get an update on its expanding company, new manufacturing premises, an upcoming clinical trial in 2023 and nomination for a KUKA Innovation Award 2022.

Listen in now to this podcast No. 137!